Targeted Oncology6h
FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA in mCRPC
The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...
Pentagon spent millions on transgender research and accommodation, records show
As the Department of Government Efficiency looms, the Department of Defense is still paying out grants to accommodate ...
Cancer Therapy Advisor19h
Virtual Second Opinions Recommend Changes to Cancer Treatment More Than Half the Time
Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.
precisionmedicineonline7h
Real-World Studies Aim to Optimize Treatment Sequence for Novartis' Pluvicto in Prostate Cancer
Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.
Combining protein therapy and focused ultrasound therapy can improve cancer treatment
Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...
verywellhealth2h
What Are the Pros and Cons of Hormone Pellets?
Hormone pellets are a type of hormone replacement therapy (HRT) sometimes taken for menopause symptom relief. Pros include convenience and improved symptoms, but there are also a few cons to this ...
Hosted on MSN3h
Researchers use focused ultrasound to shrink prostate tumors, no surgery needed
Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...